Showing results (691-700 of 1,330) with videos related to

Sort By:
Pageof 133
Journal of Cutaneous Pathology|March 13, 2008
The cutaneous manifestations of atypical complete DiGeorge syndrome: a histopathologic and immunohistochemical studyMaria Angelica Selim, Mary L Markert, James L Burchette, et al.
Advances in Patient-Reported Outcomes|August 27, 2025
Comparing three measures of sleep disturbance in persons with chronic low back and neck painNabeel Qureshi, Daniel Siconolfi, Anthony Rodriguez, et al.
Schizophrenia Research|May 10, 2001
Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophreniaM J Webster, C Shannon Weickert, M M Herman, et al.
Planta|January 1, 1995
Binding-protein expression is subject to temporal, developmental and stress-induced regulation in terminally differentiated soybean organsA Kalinski, D L Rowley, D S Loer, et al.
Journal of Psychiatric Research|March 1, 1997
Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenicsS E Bachus, T M Hyde, M M Herman, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 23, 2024
The PROMIS-16 reproduces the PROMIS-29 physical and mental health summary scores accurately in a probability-based internet panelRon D Hays, Patricia M Herman, Anthony Rodriguez, et al.
Journal of Medical Internet Research|August 4, 2023
Effects of Excluding Those Who Report Having "Syndomitis" or "Chekalism" on Data Quality: Longitudinal Health Survey of a Sample From Amazon's Mechanical TurkRon D Hays, Nabeel Qureshi, Patricia M Herman, et al.
Molecular Cancer Therapeutics|June 29, 2011
Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell linesFrédéric R Santer, Philipp P S Höschele, Su Jung Oh, et al.
Endocrine-Related Cancer|August 6, 2013
IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9Holger H H Erb, Regina V Langlechner, Patrizia L Moser, et al.
Therapeutic Advances in Urology|March 17, 2025
Pembrolizumab and olaparib in a cisplatin-refractory testicular cancer patient with a high TMB: first case reportNils C H van Creij, Gerald Klinglmair, Leonhard Gruber, et al.
Pageof 133